2010 hematopoietic and lymphoid neoplasms
DESCRIPTION
ICD-O-3 vs Hematopoietic Database ICD-O-3 issued in 2000; effective for cases diagnosed 1/1/2001 and forward 7 Errata issues Preferred names and synonyms are unchangedTRANSCRIPT
![Page 1: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/1.jpg)
2010 Hematopoietic and Lymphoid Neoplasms
ICD-O-3 and the Hematopoietic Database: Differences
![Page 2: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/2.jpg)
ICD-O-3 vs Hematopoietic Database ICD-O-3 issued in 2000; effective for
cases diagnosed 1/1/2001 and forward
7 Errata issues Preferred names and synonyms are
unchanged
![Page 3: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/3.jpg)
ICD-O-3 vs Hematopoietic Database Hemato DB:
Created for cancer registrars and cancer registries
2008 WHO Classification of Hematopoietic and Lymphoid Neoplasms.
![Page 4: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/4.jpg)
ICD-O-3 vs Hematopoietic Database Hemato DB Contents:
Synonyms New Terms
• Updates to preferred terms and synonyms Variants Abbreviations and Acronyms
![Page 5: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/5.jpg)
ICD-O-3 vs Hematopoietic Database Changes in histology names:
9702/3: Mature T-cell lymphoma, NOS (ICD-O-3)
WHO Terms:• Peripheral T-cell lymphoma, NOS• Anaplastic large cell lymphoma, ALK negative
9730/3: Myeloid Sarcoma (ICD-O-3) WHO Term:
• Chloroma
![Page 6: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/6.jpg)
ICD-O-3 vs Hematopoietic Database New Synonyms:
9709/3: Cutaneous T-cell lymphoma (ICD-O-3)
WHO Terms:• Primary cutaneous CD4 positive
small/medium cell T-cell lymphoma• Primary cutaneous CD8 positive aggressive
epidemotropic cytoxic T-cell lymphoma
![Page 7: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/7.jpg)
ICD-O-3 vs Hematopoietic Database New Terms:
9712/3: Intravascular large B-cell lymphoma
9725/3: Hydro vacciniforme-like lymphoma
9737/3: Intravascular large B-cell lymphoma
![Page 8: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/8.jpg)
ICD-O-3 vs Hematopoietic Database Variants:
Hairy cell leukemia (HCL) variant• ICD-O-3: 9940/3 (HCL)• Hemato DB: 9591/3 (HCL variant)
Abstractor Notes:• 9591/3 includes “splenic diffuse red pulp
small B-cell lymphoma”• 9690/3 includes “primary intestinal
follicular lymphoma”
![Page 9: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/9.jpg)
ICD-O-3 vs Hematopoietic Database Abstractor Notes also include:
Expected primary site Specific terms associated with “NOS”
codes Abbreviations, acronyms Reportability Linkage, consolidation, quality
improvement and abstraction notes
![Page 10: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/10.jpg)
ICD-O-3 vs Hematopoietic Database Conclusions:
Hemato DB used to:• Find correct histology code• Determine primary site• Include definitive diagnostic tests• Disease-specific genetics data• Disease immunophenotyping• Detailed abstractor notes
Report any changes to histology to the CTR
![Page 11: 2010 Hematopoietic and Lymphoid Neoplasms](https://reader036.vdocuments.us/reader036/viewer/2022082510/5a4d1b0a7f8b9ab05998a332/html5/thumbnails/11.jpg)
ICD-O-3 vs Hematopoietic Database Questions?
This work was supported by Contract HHSN26120000024C between the National Cancer Institute and the Connecticut Department of Public Health.